RCP
Rho Capital Partners Portfolio holdings
AUM
$20.4M
This Quarter Return
-19.86%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$179M
AUM Growth
+$179M
(-84%)
Cap. Flow
-$552M
Cap. Flow
% of AUM
-307.74%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
ChargePoint
CHPT
|
$402M |
| 2 |
ON24
ONTF
|
$129M |
| 3 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$21.4M |
Sector Composition
| 1 | Healthcare | 48.32% |
| 2 | Consumer Discretionary | 45.17% |
| 3 | Communication Services | 6.21% |
| 4 | Technology | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ChargePoint
CHPT
$250M
| $81M | 45.17% |
4,053,257
-20,089,084
| -83% | -$402M |
|
|
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $79.2M | 44.14% |
3,766,666
| – | – |
|
3
LiveOne
LVO
$58.1M
| $11.1M | 6.21% |
3,724,137
| – | – |
|
4
Mersana Therapeutics
MRSN
$35M
| $7.51M | 4.19% |
796,458
| – | – |
|
5
Senseonics Holdings
SENS
$369M
| $541K | 0.3% |
159,601
| – | – |
|
|
6
ON24
ONTF
$235M
| – | – |
-3,637,894
| Closed | -$129M |
|
|
TVRD
7
Tvardi Therapeutics, Inc. Common Stock
TVRD
$277M
| – | – |
-1,499,058
| Closed | -$21.4M |
|